#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3991951	B	Inhibition of human recombinant Glepp-1 catalytic domain using DiFMUP as substrate after 30 mins by fluorescence assay	Homo sapiens	7	ALA3991941	single protein format	Patent Bioactivity Data
2.	ALA3991952	F	Inhibition of MCP-1/CCL2-induced chemotaxis in human THP1 cells incubated for 3 hrs by Beckman Coulter counting based cell counting method	Homo sapiens	3	ALA3991941	cell-based format	Patent Bioactivity Data
3.	ALA3991953	F	Antiinflammatory activity in C3H mouse model of thioglycollate-induced lymphocyte recruitment assessed as decrease in blood neutrophils at 30 mg/kg, po dosed 15 mins before thioglycollate stimulation by Beckman Coulter counting based cell counting method relative to untreated control	Mus musculus	11	ALA3991941	organism-based format	Patent Bioactivity Data
4.	ALA3991954	F	Antiinflammatory activity in C3H mouse model of thioglycollate-induced lymphocyte recruitment assessed as decrease in blood lymphocytes at 30 mg/kg, po dosed 15 mins before thioglycollate stimulation by Beckman Coulter counting based cell counting method relative to untreated control	Mus musculus	11	ALA3991941	organism-based format	Patent Bioactivity Data
5.	ALA3991955	F	Antiinflammatory activity in C3H mouse model of thioglycollate-induced lymphocyte recruitment assessed as decrease in blood macrophages at 30 mg/kg, po dosed 15 mins before thioglycollate stimulation by Beckman Coulter counting based cell counting method relative to untreated control	Mus musculus	11	ALA3991941	organism-based format	Patent Bioactivity Data
6.	ALA3991956	F	Reduction in colon weight in Balb/c mouse model of dextran sodium sulfate-induced ulcerative colitis at 10 mg/kg, po dosed twice daily at days 3,4, 5 and 6 after the induction of the ulcerative colitis and measured 7 days post ulcerative colitis induction	Mus musculus	2	ALA3991941	organism-based format	Patent Bioactivity Data
7.	ALA3991957	F	Reduction in colon weight in Balb/c mouse model of dextran sodium sulfate-induced ulcerative colitis at 30 mg/kg, po dosed twice daily at days 3,4, 5 and 6 after the induction of the ulcerative colitis and measured 7 days post ulcerative colitis induction	Mus musculus	2	ALA3991941	organism-based format	Patent Bioactivity Data
8.	ALA3991958	F	Reduction in colon weight in Balb/c mouse model of dextran sodium sulfate-induced ulcerative colitis at 100 mg/kg, po dosed twice daily at days 3,4, 5 and 6 after the induction of the ulcerative colitis and measured 7 days post ulcerative colitis induction	Mus musculus	1	ALA3991941	organism-based format	Patent Bioactivity Data
9.	ALA3991959	F	Reduction in splenomegaly in Balb/c mouse model of dextran sodium sulfate-induced ulcerative colitis at 30 mg/kg, po dosed twice daily at days 3,4, 5 and 6 after the induction of the ulcerative colitis and measured 7 days post ulcerative colitis induction	Mus musculus	2	ALA3991941	organism-based format	Patent Bioactivity Data
10.	ALA3991960	F	Reduction in splenomegaly in Balb/c mouse model of dextran sodium sulfate-induced ulcerative colitis at 100 mg/kg, po dosed twice daily at days 3,4, 5 and 6 after the induction of the ulcerative colitis and measured 7 days post ulcerative colitis induction	Mus musculus	2	ALA3991941	organism-based format	Patent Bioactivity Data
11.	ALA3991961	F	Reduction in clinical score in Balb/c mouse model of dextran sodium sulfate-induced ulcerative colitis at 30 mg/kg, po dosed twice daily at days 3,4, 5 and 6 after the induction of the ulcerative colitis and measured 7 days post ulcerative colitis induction (Rvb = -29%)	Mus musculus	1	ALA3991941	organism-based format	Patent Bioactivity Data
12.	ALA3991962	F	Reduction in clinical score in Balb/c mouse model of dextran sodium sulfate-induced ulcerative colitis at 30 mg/kg, po dosed twice daily at days 3,4, 5 and 6 after the induction of the ulcerative colitis and measured 7 days post ulcerative colitis induction (Rvb = -21%)	Mus musculus	1	ALA3991941	organism-based format	Patent Bioactivity Data
13.	ALA5233989	B	Binding affinity to SHP2 (unknown origin) assessed as inhibition constant	Homo sapiens	1	ALA5233224	single protein format	Scientific Literature
14.	ALA5233990	B	Binding affinity to GLEPP1 (unknown origin) assessed as inhibition constant	Homo sapiens	1	ALA5233224	single protein format	Scientific Literature